GF
ETTX

Gabelli Funds’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Gabelli Funds’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-59,100
Closed -$130K – 1457
2022
Q2 		$130K Hold
59,100
– – ﹤0.01% 1222
2022
Q1 		$111K Buy
+59,100
New +$108K ﹤0.01% 1283

Gabelli Funds's ETTX Position: Q3 2022 in Review

Gabelli Funds sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 59,100 shares — an estimated $130K sold.

Gabelli Funds first reported a position in ETTX in Q1 2022 and held it in 2 quarters. The position peaked at $130K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • Gabelli Funds reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • Gabelli Funds sold 59,100 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $130K.
  • Gabelli Funds first reported a position in Entasis Therapeutics Holdings Inc. in Q1 2022 and held it in 2 quarters.
  • Gabelli Funds's Entasis Therapeutics Holdings Inc. position peaked at $130K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Gabelli Funds's 13F filing for Q3 2022, filed 10 Nov 2022.